<DOC>
	<DOC>NCT02304627</DOC>
	<brief_summary>This trial is conducted in Europe. The aim of the trial is to investigate the effect of food on the pharmacokinetics (the exposure of the trial drug in the body) of NNC0123-0000-0338 in a tablet formulation in healthy subjects.</brief_summary>
	<brief_title>Effect of Food on the Pharmacokinetics of NNC0123-0000-0338 in a Tablet Formulation in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Insulin</mesh_term>
	<criteria>Age 1864 years (both inclusive) at the time of signing informed consent Body mass index 18.528.0 kg/m^2 (both inclusive) Subject who is considered to be healthy based on the medical history, physical examination, and the results of vital signs, electrocardiogram and clinical laboratory tests performed during the screening visit, as judged by the investigator Known or suspected hypersensitivity to trial products or related products Previous participation in this trial. Participation is defined as informed consent Presence of clinically significant acute and chronic gastrointestinal symptoms (e.g. nausea, vomiting, heartburn or diarrhoea) within 2 weeks prior to first dosing, as judged by the investigator</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>